Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Jan;79(2):340-5.
doi: 10.1038/sj.bjc.6690054.

Microsatellite instability in thyroid tumours and tumour-like lesions

Affiliations
Free PMC article

Microsatellite instability in thyroid tumours and tumour-like lesions

D Lazzereschi et al. Br J Cancer. 1999 Jan.
Free PMC article

Abstract

Fifty-one thyroid tumours and tumour-like lesions were analysed for instability at ten dinucleotide microsatellite loci and at two coding mononucleotide repeats within the transforming growth factor beta (TGF-beta) type II receptor (TbetaRII) and insulin-like growth factor II (IGF-II) receptor (IGFIIR) genes respectively. Microsatellite instability (MI) was detected in 11 out of 51 cases (21.5%), including six (11.7%) with MI at one or two loci and five (9.8%) with MI at three or more loci (RER+ phenotype). No mutations in the TbetaRII and IGFIIR repeats were observed. The overall frequency of MI did not significantly vary in relation to age, gender, benign versus malignant status and tumour size. However, widespread MI was significantly more frequent in follicular adenomas and carcinomas than in papillary and Hürthle cell tumours: three out of nine tumours of follicular type (33.3%) resulted in replication error positive (RER+), versus 1 out of 29 papillary carcinomas (3.4%, P = 0.01), and zero out of eight Hürthle cell neoplasms. Regional lymph node metastases were present in five MI-negative primary cancers and resulted in MI-positive in two cases.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Oncogene. 1992 Dec;7(12):2549-53 - PubMed
    1. Cancer Res. 1989 Jul 1;49(13):3457-62 - PubMed
    1. Oncogene. 1989 Dec;4(12):1457-62 - PubMed
    1. Oncogene. 1989 Feb;4(2):159-64 - PubMed
    1. Cancer Res. 1995 Dec 1;55(23):5545-7 - PubMed

Publication types